These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8947318)

  • 1. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.
    Del Boca FK; Kranzler HR; Brown J; Korner PF
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1412-7. PubMed ID: 8947318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.
    Sprenger D
    J Clin Psychopharmacol; 1997 Oct; 17(5):425-6. PubMed ID: 9315996
    [No Abstract]   [Full Text] [Related]  

  • 3. Riboflavin as a tracer of medication compliance.
    Dubbert PM; King A; Rapp SR; Brief D; Martin JE; Lake M
    J Behav Med; 1985 Sep; 8(3):287-99. PubMed ID: 4087291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance among heavy alcohol users in clinical drug trials.
    Sullivan JT; Naranjo CA; Sellers EM
    J Subst Abuse; 1988-1989; 1(2):183-94. PubMed ID: 2980999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.
    Kabel DI; Petty F
    Alcohol Clin Exp Res; 1996 Jun; 20(4):780-4. PubMed ID: 8800399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing compliance of drug taking--a simple bed side method.
    Thilothammal N; Krishnamurthy PV; Banu K; Gandhimathy S
    Indian Pediatr; 1995 Mar; 32(3):295-9. PubMed ID: 8613283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How useful is riboflavin as a tracer of medication compliance?
    Babiker IE; Cooke PR; Gillett MG
    J Behav Med; 1989 Feb; 12(1):25-38. PubMed ID: 2746641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with disulfiram treatment of alcoholism.
    Fuller R; Roth H; Long S
    J Chronic Dis; 1983; 36(2):161-70. PubMed ID: 6337171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models.
    Maximino C; Puty B; Benzecry R; Araújo J; Lima MG; de Jesus Oliveira Batista E; Renata de Matos Oliveira K; Crespo-Lopez ME; Herculano AM
    Neuropharmacology; 2013 Aug; 71():83-97. PubMed ID: 23541719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial.
    Ramanujam VS; Nayeem F; Anderson KE; Kuo YF; Chen NW; Ju H; Lu LW
    Biomarkers; 2017 Sep; 22(6):508-516. PubMed ID: 27918196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement.
    Herron AJ; Mariani JJ; Pavlicova M; Parrinello CM; Bold KW; Levin FR; Nunes EV; Sullivan MA; Raby WN; Bisaga A
    Drug Alcohol Depend; 2013 Feb; 128(1-2):77-82. PubMed ID: 22921475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking.
    George DT; Rawlings R; Eckardt MJ; Phillips MJ; Shoaf SE; Linnoila M
    Alcohol Clin Exp Res; 1999 Feb; 23(2):272-8. PubMed ID: 10069556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New methodologies for pharmacological treatment trials for alcohol dependence.
    Anton RF
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):3A-9A. PubMed ID: 8904988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.
    Malec E; Malec T; Gagné MA; Dongier M
    Alcohol Clin Exp Res; 1996 Apr; 20(2):307-12. PubMed ID: 8730222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
    Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
    J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder.
    de Klerk E
    J Clin Psychiatry; 2001; 62 Suppl 22():43-7. PubMed ID: 11599648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.